spacer
home > ebr > winter 2019 > gates and doors
PUBLICATIONS
European Biopharmaceutical Review

Gates and Doors

Important discoveries have enabled continued progress in biopharmaceutical sciences; the Nobel Prize in Chemistry was awarded jointly to Frances Arnold for the directed evolution of enzymes and to George Smith and Sir Gregory Winter for the phage display of peptides and antibodies. This work will accelerate the pace of biopharmaceutical drug discovery and open up opportunities for new agents. The Nobel Prize in physiology or medicine was awarded to James Allison and Tasuku Honjo for the discovery of cancer therapy by the inhibition of negative immune regulation. The result of their research, immune checkpoint therapy, is recognised as the fourth pillar in the fight against cancer, supplementing surgery, radiation, and chemotherapy. It has fundamentally changed the outcome for certain groups of patients with advanced cancers.

At the same time, much work remains to be done in the quest to mitigate chronic diseases. The war on cancer persists as steady progress is made in precision medicine. The majority of recent drug approvals have received breakthrough therapy designation by the FDA. These focus mainly on targeted therapies, reflecting greater understanding of the underlying mechanisms. Among the major tumour types, biomarkers help specify patient treatment protocols and to distinguish different cancers, beyond more than just tissue types.

Cancer immunotherapy studies number in the thousands. The enthusiasm for this approach relates to the stunning success achieved in just a few years – alone or in combination protocols. After initial tissue-specific experience, the field has quickly evolved toward a tissue-agnostic paradigm, based on genetic biomarkers.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo includes Sheremetyevo Airport near Moscow to its cargo flights network.

As the fastest growing brand among the global air cargo carriers with its extensive flights network, Turkish Cargo included Sheremetyevo Airport (SVO), known as being the most important airport in Russia in terms of cargo activities, to its direct cargo flight destinations network.
More info >>

White Papers

Blockbuster Drugs Need Blockbuster Components

West Pharmaceutical Services, Inc.

Many of the world’s blockbuster drugs are now delivered via a prefilled syringe system or auto-injector. To ensure patient safety, pharmaceutical manufacturers need high-quality components that feature reduced particulates and ensure consistency of delivery while fitting the changing needs of higher-volume delivery systems.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement